SCHEMBL1591407

SCHEMBL1591407

O=S(=O)(Nc1c[nH]c2ccccc12)c1c(Cl)nc2n1CCS2

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 6/20 0.57
NPC1 O15118 1/20 0.40
TP53 P04637 1/20 0.40
RAB9A P51151 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
ALDH1A1 P00352 3/20 0.35
KDM4E B2RXH2 1/20 0.35
STING1 Q86WV6 2/20 0.34
MAPT P10636 3/20 0.34
POLB P06746 2/20 0.34
TDO2 P48775 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
TNKS2 Q9H2K2 1/20 0.33
LMNA P02545 1/20 0.33
MEN1 O00255 1/20 0.33
HTT P42858 1/20 0.33
KMT2A Q03164 1/20 0.33
ACLY P53396 1/20 0.32
RAD51 Q06609 1/20 0.32
NR3C1 P04150 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1590856 0.78 HTR6 (0.53) HTR6NPC1TP53RAB9ASMN1; SMN2
SCHEMBL1423219 0.76 ACLY (0.56) HTR6NPC1RAB9AHTTACLY
SCHEMBL1590988 0.75 ALDH1A1 (0.51) HTR6ALDH1A1KDM4EPOLBLMNA
SCHEMBL1590132 0.70 HTR6 (0.67) HTR6SMN1; SMN2ALDH1A1POLBLMNA
SCHEMBL12702633 0.70 HTR6 (0.73) HTR6ALDH1A1POLBTDP1MEN1
SCHEMBL1590499 0.69 HTR6 (0.63) HTR6SMN1; SMN2
SCHEMBL12702571 0.69 HTR6 (0.62) HTR6
Hydrochloric Acid SCHEMBL1590775 0.67 HTR6 (0.49) HTR6RAB9ASMN1; SMN2ALDH1A1KDM4E
SCHEMBL1591157 0.67 HTR6 (0.49) HTR6RAB9ASMN1; SMN2ALDH1A1KDM4E
SCHEMBL1423066 0.67 NPC1 (0.44) HTR6NPC1TP53RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2324035-A1 SUBSTITUTED N-PHENYL-2,3-DIHYDROIMIDAZO[2,1-B]THIAZOLE-5-SULFONAMIDE DERIVATIVES AS 5-HT6 LIGANDS Laboratorios Del. Dr. Esteve, S.A. (ES) 2011-05-25 EP claimed
US-20110092540-A1 SUBSTITUTED N-PHENYL-2,3-DIHYDROIMIDAZO[2,1-B]THIAZOLE-5-SULFONAMIDE DERIVATIVES AS 5-HT6 LIGANDS LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2011-04-21 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110092540-A1 SUBSTITUTED N-PHENYL-2,3-DIHYDROIMIDAZO[2,1-B]THIAZOLE-5-SULFONAMIDE DERIVATIVES AS 5-HT6 LIGANDS HTR6, HTR2A, HTR4 HTR6 1/4885NPC1 882/4885TP53 4646/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.